Attovia Therapeutics Inc.(ATTO:US)
Market Cap$626.79M
Key Metrics
Price$13.73
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$43.3M
Total Assets$146.09M
Net Assets-$125.52M
Total Debt$4.8M
Key Metrics
Price$13.73
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$43.3M
Total Assets$146.09M
Net Assets-$125.52M
Total Debt$4.8M
Financials
| Name | Mar 31, 2026 | Mar 31, 2025 | Sep 30, 2022 | Jun 30, 2022 |
|---|---|---|---|---|
Revenue | $0 | $0 | $346.8M | $363.83M |
Cost of Revenue | - | - | $35.32M | $30.08M |
Gross Profit | - | - | $311.48M | $333.75M |
| $19.96M | $16.1M | $273.08M | $305.41M | |
| Research and Development | $16.75M | $11.86M | - | - |
| Selling, General, and Administrative | $3.21M | $4.25M | $255.57M | $283.65M |
| Other Operating Expenses | - | - | $17.51M | $21.76M |
Operating Income | -$19.96M | -$16.1M | $7.93M | -$2.95M |
| $1.3M | $953K | $7.06M | -$12.89M | |
| Non-Operating Interest Income | $1.33M | $1.13M | $5.73M | $2.79M |
| Non-Operating Interest Expense | - | - | $13.45M | $20.35M |
| Other Income/Expense | -$27K | -$173K | $14.77M | $4.68M |
Income Before Tax | -$18.66M | -$15.15M | $14.99M | -$15.83M |
Income Tax | - | - | $13.5M | -$3.74M |
Net Income | -$18.66M | -$15.15M | $1.49M | -$12.09M |
Minority Interests | - | - | - | - |
Preferred Stock Dividends | $0 | $271K | - | - |
Net Income to Common | -$18.66M | -$15.42M | $1.49M | -$12.09M |
Shares Outstanding (Basic) | 25.67M | 25.67M | 14.6M | 14.58M |
Shares Outstanding (Diluted) | 25.67M | 25.67M | 14.6M | 14.58M |
EPS (Basic) | -$0.73 | -$0.60 | $0.10 | -$0.83 |
EPS (Diluted) | -$0.73 | -$0.60 | $0.10 | -$0.83 |
EBIT | -$19.96M | -$16.1M | $28.43M | $4.52M |
EBITDA | -$19.71M | -$15.96M | $44.13M | $31.27M |